These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 37413784)

  • 1. MAPT rs17649553 T allele is associated with better verbal memory and higher small-world properties in Parkinson's disease.
    Chen Z; Wu B; Li G; Zhou L; Zhang L; Liu J
    Neurobiol Aging; 2023 Sep; 129():219-231. PubMed ID: 37413784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
    Winder-Rhodes SE; Hampshire A; Rowe JB; Peelle JE; Robbins TW; Owen AM; Barker RA
    Neurobiol Aging; 2015 Mar; 36(3):1519-28. PubMed ID: 25577413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.
    Desikan RS; Schork AJ; Wang Y; Witoelar A; Sharma M; McEvoy LK; Holland D; Brewer JB; Chen CH; Thompson WK; Harold D; Williams J; Owen MJ; O'Donovan MC; Pericak-Vance MA; Mayeux R; Haines JL; Farrer LA; Schellenberg GD; Heutink P; Singleton AB; Brice A; Wood NW; Hardy J; Martinez M; Choi SH; DeStefano A; Ikram MA; Bis JC; Smith A; Fitzpatrick AL; Launer L; van Duijn C; Seshadri S; Ulstein ID; Aarsland D; Fladby T; Djurovic S; Hyman BT; Snaedal J; Stefansson H; Stefansson K; Gasser T; Andreassen OA; Dale AM;
    Mol Psychiatry; 2015 Dec; 20(12):1588-95. PubMed ID: 25687773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
    Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
    Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of the GRN  rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
    Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
    Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro.
    Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JB
    Mov Disord; 2014 Nov; 29(13):1606-14. PubMed ID: 24375821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and sex differentially shape brain networks in Parkinson's disease.
    Chen Z; Wu B; Li G; Zhou L; Zhang L; Liu J
    CNS Neurosci Ther; 2023 Jul; 29(7):1907-1922. PubMed ID: 36890620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.
    Arslan DB; Gurvit H; Genc O; Kicik A; Eryurek K; Cengiz S; Erdogdu E; Yildirim Z; Tufekcioglu Z; Uluğ AM; Bilgic B; Hanagasi H; Tuzun E; Demiralp T; Ozturk-Isik E
    J Neural Transm (Vienna); 2020 Sep; 127(9):1285-1294. PubMed ID: 32632889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
    Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
    Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson's disease: A meta-analysis.
    Lu SS; Gong FF; Feng F; Hu CY; Qian ZZ; Wu YL; Yang HY; Sun YH
    Biochem Biophys Res Commun; 2014 Oct; 453(3):653-61. PubMed ID: 25305495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.
    Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JB
    PLoS One; 2016; 11(6):e0157924. PubMed ID: 27336847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Nombela C; Rowe JB; Winder-Rhodes SE; Hampshire A; Owen AM; Breen DP; Duncan GW; Khoo TK; Yarnall AJ; Firbank MJ; Chinnery PF; Robbins TW; O'Brien JT; Brooks DJ; Burn DJ; ; Barker RA
    Brain; 2014 Oct; 137(Pt 10):2743-58. PubMed ID: 25080285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
    Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
    Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic influences on cognitive decline in Parkinson's disease.
    Morley JF; Xie SX; Hurtig HI; Stern MB; Colcher A; Horn S; Dahodwala N; Duda JE; Weintraub D; Chen-Plotkin AS; Van Deerlin V; Falcone D; Siderowf A
    Mov Disord; 2012 Apr; 27(4):512-8. PubMed ID: 22344634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.
    Yu L; Huang J; Zhai D; Liu L; Guo K; Long X; Xiong J; Zhang Z; Wang Y; Zhao Y; Wu P; Wang D; Lin Z; Wu J; Xiong N; Wang T
    BMC Neurosci; 2014 Apr; 15():54. PubMed ID: 24779391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Parkinson's Disease GWAS-Linked Loci with Alzheimer's Disease in Han Chinese.
    Zhu XC; Cao L; Tan MS; Jiang T; Wang HF; Lu H; Tan CC; Zhang W; Tan L; Yu JT
    Mol Neurobiol; 2017 Jan; 54(1):308-318. PubMed ID: 26738859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
    Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
    Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.